Towards a peptide-based suspension array for the detection of pestivirus antibodies in swine  by van der Wal, Fimme J. et al.
T
p
F
C
A
R
R
A
A
K
P
S
C
S
e
f
2
b
g
h
B
a
d
b
o
a
a
p
t
i
t
r
h
0Journal of Virological Methods 235 (2016) 15–20
Contents lists available at ScienceDirect
Journal  of  Virological  Methods
j o ur na l ho me  pa ge: www.elsev ier .com/ locate / jv i romet
owards  a  peptide-based  suspension  array  for  the  detection  of
estivirus  antibodies  in  swine
imme  J.  van  der  Wal ∗, Tinka  Jelsma,  Helmi  Fijten,  René  P.  Achterberg,  Willie  L.A.  Loeffen
entral Veterinary Institute, Part of Wageningen UR, P.O. Box 65, 8200 AB Lelystad, The Netherlands
rticle history:
eceived 27 November 2015
eceived in revised form 15 February 2016
ccepted 1 April 2016
vailable online 7 May  2016
eywords:
eptide
uspension array
a  b  s  t  r  a  c  t
Classical  swine  fever  (CSF)  is a highly  contagious  and  lethal  disease  in  swine.  Serological  tests  for  the
diagnosis  of  CSF  need  not  only  to  detect  antibodies  against  CSFV,  but  also  need  to  differentiate  these  from
antibodies  against  other  pestiviruses.  To  investigate  the  possibilities  of  speciﬁc  peptide-based  serology,
various  synthetic  peptides  that  represent  a well-described  linear  epitope  of the  CSFV  E2  protein  (TAVSPT-
TLR)  were  used  to  test  the  viability  of a peptide-based  suspension  array  for the  detection  of  antibodies
against  pestiviruses  in swine.
The results  show  that  N-terminally  biotinylated  peptides  can  bind  to avidin  conjugated  beads,  and
function  in  detection  of  the corresponding  monoclonal  antibody  WH303.  There  are  indications  that  thelassical swine fever virus
erum
length  of  the  spacer  between  epitope  and  biotin  affect  the  efﬁciency  of  the  peptide-antibody  interaction.  A
protocol was  established  that  enables  probing  for antibodies  in porcine  sera,  where  neutravidin-blocking
of  serum  and the  use  of empty  control  beads  for normalization  was  crucial. With  a set  of porcine  sera
with  antibodies  against  various  pestiviruses,  the  proof  of  concept  of a peptide-based  suspension  array
for speciﬁc  detection  of  antibodies  against  pestiviruses  in porcine  sera  was  demonstrated.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  licenseClassical swine fever (CSF) is a highly contagious and lethal dis-
ase in swine and is listed as notiﬁable to the World Organisation
or Animal Health (OIE; Ofﬁce International des Epizooties) (OIE,
014b). CSF virus (CSFV), bovine viral diarrhoea (BVD) virus and
order disease (BD) virus are all closely related and belong to the
enus Pestivirus of the Flaviviridae family. Swine are the natural
ost for CSFV, but may  also be infected by BVD virus (BVDV) and
D virus (BDV), which have cattle, respectively sheep and goats,
s their main hosts (Le Potier et al., 2006). Serological tests for the
iagnosis of CSF need not only to detect antibodies against CSFV,
ut also need to differentiate these from antibodies against BVDV
r BDV. Accurate serological diagnosis of CSF may  be difﬁcult as
ntibodies against the two main immunogenic proteins of BVDV
nd BDV, E2 and Erns, can cross-react with the orthologous CSFV
roteins used in the diagnostic assays (Wensvoort et al., 1989). For
Abbreviations: AEEA, [2-(2-aminoethoxy)ethoxy]-acetic acid; PE, phycoery-
hrin; SAPE, streptavidin conjugated with phycoerythrin; MFI, median ﬂuorescence
ntensity; PBST, phosphate buffered saline with Tween.
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ﬁnal conﬁrmation of testing for CSFV antibodies and differentia-
tion from antibodies against BVDV or BDV, a virus neutralisation
test (VNT) is currently prescribed (Anonymous, 2002; OIE, 2014a).
Disadvantages of the VNT are that i) the test is laborious and takes
at least 3 to 5 days, ii) the test requires the ability and facility to
work with live virus, and iii) the test is in some cases not capable
of accurately discriminating between antibodies against CSFV and
other pestiviruses (Wieringa-Jelsma et al., 2006). The latter may
lead to false-positives, especially in regions with a high BVDV/BDV
prevalence in swine, or false-negatives in case of double infections.
Ideally, a fast serological test would become available that reliably
differentiates between antibodies against the three pestiviruses.
For a complete serological pestivirus assay, a panel with multi-
ple speciﬁc antigens is desirable, e.g. a set of peptides representing
unique B-cell epitopes of the major immunogenic proteins of CSFV,
BVDV, and BDV. Although work is ongoing to identify peptides
that mimic  or represent epitopes of the immunodominant pro-
teins of CSFV (Lin et al., 2010; Meyer et al., 2012; Peng et al.,
2008; Zhang et al., 2006), or indeed of all three pestiviruses (Jelsma,
unpublished), a complete panel of differentiating peptides for all
pestiviruses is as yet not available. Preceding the existence of a
comprehensive peptide set, in the present study the technical pos-
sibilities and requirements for multiplex serology with peptides as
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table  1
Peptides. Six peptide variants containing the TAVSPTTLR epitope were synthesized
and puriﬁed (Pepscan, Lelystad, The Netherlands). In three long peptide variants, an
N-terminal biotin was separated from the epitope by (combinations of) a ﬂexible
peptide spacer (GGSGGS), a [2-(2-aminoethoxy)ethoxy]-acetic acid (AEEA) spacer
consisting of 5 units (sp5), or a stretch of 10 amino acids that normally precede
TAVSPTTLR in CSFV E2 (PIGWTGVIES). Three short peptide variants were made with
no  biotin, or with an N- or C-terminal biotin separated from the epitope by one AEEA
spacer (sp1). The short peptides carried two extra amino acids from CSFV E2 (TE)
behind the epitope, long variants carried four (TEVV).
Designation Peptide sequence
CSFV1 biotin-GGSGGSPIGWTGVIESTAVSPTTLRTEVV
CSFV2 biotin-sp5-PIGWTGVIESTAVSPTTLRTEVV
CSFV3 biotin-sp5-TAVSPTTLRTEVV
CSFV4-N-bio biotin-sp1-TAVSPTTLRTE
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oCSFV4-C-bio TAVSPTTLRTE-sp1-K-biotin
CSFV4-no-bio H-sp1-TAVSPTTLRTE
ntigens were investigated, using a bead-based suspension array
Christopher-Hennings et al., 2013) as technical platform. To this
nd, various synthetic peptides, that represent a well-described
inear epitope of the E2 protein from CSFV (TAVSPTTLR) (Lin et al.,
000), were used to test the viability of a peptide-based suspension
rray for the detection of antibodies against pestiviruses in swine.
First, beads carrying the TAVSPTTLR speciﬁc monoclonal anti-
ody WH303 were used to investigate whether biotinylated
eptides could bind simultaneously to antibodies and strepta-
idin (SA) conjugated with the ﬂuorophore phycoerythrin (PE). To
mmobilize antibodies on beads, 5 g WH303 (AHVLA Scientiﬁc,
eybridge, United Kingdom) was coupled to 2.5 × 106 carboxy-
ated paramagnetic beads (MagPlex microspheres, Luminex, Den
osch, The Netherlands) with a generic two-step carbodiimide
oupling, using sulfo-N-hydroxysulfosuccinimide and 1-ethyl-
-[3-dimethylaminopropyl] carbodiimide hydrochloride (Pierce,
hermo Fisher Scientiﬁc, Rockford, IL USA), as described (Angeloni
t al., 2014). For the experiment, the resulting beads were incu-
ated with a serial dilution of various peptides containing the
AVSPTTLR epitope (Table 1). Assays were performed essentially
s described (Van der Wal  et al., 2013): beads were washed
rior to the assay, in between the respective incubations, and
rior to analysis. Captured peptides were detected using strepta-
idin conjugated with R-phycoerythrin (SAPE; Life Technologies,
leiswijk, The Netherlands), diluted 1:1000 in phosphate buffered
aline (pH7.2) with 0.05% Tween 20 (Merck) (PBST). Results were
xpressed as median ﬂuorescence intensity (MFI).
The use of peptides with long spacers (CSFV1-3) resulted in
cquisition of ﬂuorescence upon addition of SAPE (Fig. 1) in a
oncentration dependent manner. At the highest peptide concen-
ration tested (40000 nM), high MFIs, ranging from 1300 to 2600
FI, were acquired. When a lower peptide concentration was used,
he signal remained below 200 MFI. No substantial signal was
cquired with beads carrying comparable peptides with a short
pacer (CSFV4-N-bio, CSFV4-C-bio) or with beads that had been
repared with a control peptide with no biotin (CSFV4-no-bio)
Fig. 1). These results show that, in the current setup, the three long
iotinylated TAVSPTTLR peptide variants can bind simultaneously
o a speciﬁc monoclonal antibody and to streptavidin. This capa-
ility is a prerequisite for the next step in setting up an assay, for
hich avidin conjugated beads loaded with biotinylated peptides
re used to capture serum antibodies.
Next, ﬁve bead sets conjugated with avidin were loaded with
ne of ﬁve biotinylated TAVSPTTLR peptide variants (cf. Table 1)
hrough an avidin-biotin interaction, and one additional bead set
as incubated with a control peptide with no biotin. To this end,
aramagnetic beads carrying avidin (low capacity, Radix BioSolu-
ions, Georgetown, TX, USA) were loaded with peptides at 0, 40, 400
r 4000 nM,  essentially as described (Angeloni et al., 2014), using agical Methods 235 (2016) 15–20
magnet to pellet beads instead of centrifugation (Van der Wal  et al.,
2013). Where desired, beads were blocked after peptide binding
with 4000 nM biotin for 30 min  in the dark at room temperature on
a plate shaker (approx. 600 rpm).
The resulting bead sets were used to investigate whether mon-
oclonal antibody WH303 could bind to immobilized peptides as
follows. Beads were used to capture monoclonal antibody WH303
(2 g/ml in PBST) in an assay, essentially as described above. Cap-
tured monoclonal antibodies were detected with PE-conjugated
goat-antimouse (1:1000) (Santa Cruz Biotechnology, Heidelberg,
Germany). Results were expressed as MFI.
Bead sets carrying long peptides were capable of binding
WH303, with ﬂuorescent signals ranging from 1200 to 1900 MFI
(Fig. 2, left panel; CSFV1-3). The signal strength was independent
of the peptide concentration used during loading of peptides onto
beads. This suggests that the avidin beads are saturated with pep-
tides already at a peptide concentration of 40 nM.  Both the empty
control beads (for each peptide) and the beads incubated with a
control buffer (PBST) acquired only minute amounts of ﬂuores-
cence (< 200 MFI) (Fig. 2A). Use of beads carrying short biotinylated
peptide variants (CSFV4-N-bio, CSFV4-C-bio), or beads prepared
in presence of a peptide without biotin (CSFV4-no-bio), resulted
in signals that remained below 200 MFI, no matter if WH303 or
PBST was used as ‘sample’. Taken together, these results demon-
strate that, after immobilization on a surface coated with avidin,
N-terminally biotinylated TAVSPTTLR peptides with a consider-
able distance between epitope and biotin, are capable of catching
antibodies with afﬁnity for TAVSPTTLR.
Notably, in absence of antibodies, the background signal on
empty beads (0 nM)  was  higher than the signals on beads carrying
peptides, which may  suggest the need for a blocking procedure. To
investigate this, a similar experiment was performed with beads
that were blocked with biotin after loading with peptides. These
beads delivered essentially the same results as the beads that were
not blocked with biotin. MFIs of peptide CSFV1-3 ranged from
1300 to 2100 MFI  (Fig. 2B), but as opposed to the previous experi-
ment, lower background signals on empty beads were observed (all
beads treated with 0 nM peptide or with CSFV4-no-bio). The values
obtained with the corresponding empty beads (0 nM)  were used to
calculate signal to noise (S/N) ratios by dividing the signal on pep-
tide loaded beads with the signal on the empty control beads. The
S/N ratios for biotin blocked beads ranged from 26 to 58 for pep-
tides CSFV1-3, whereas S/N ratios of unblocked beads ranged from
13 to 20 (not shown). This shows that biotin blocking can improve
S/N ratios, at least for this particular assay setup.
Finally, it was  investigated whether beads carrying peptides can
be used to speciﬁcally detect CSFV antibodies in porcine sera (Fig. 3).
Beads were prepared with 4000 nM of the two  peptide variants
with the longest amino acid sequences (CSFV1 and CSFV2) and in
absence of peptide (empty control beads), both with and without
biotin blocking as described above. For the control beads a dif-
ferent bead address (colour) was  chosen. The resulting bead sets
were used for testing a panel of well-characterized swine sera (cf.
Table 2), diluted 1:50 in PBST, in essence as described above. For
each measurement however, a mixture of equal amounts of pep-
tide loaded beads and empty control beads were used. This enabled
normalization of signals as described above; the results of these
duplex assays were expressed as S/N ratios. For each condition,
cut-offs were calculated as the average of S/N ratios for non-CSFV
sera plus three times the standard deviation (not shown). Cap-
tured antibodies were detected with PE-conjugated recombinant
immunoglobulin binding protein A/G (ProtAG). Non-speciﬁc bind-
ing of ProtAG-PE to avidin beads was prevented by pre-treating
diluted serum (1:50 in PBST) with 100 g/ml neutravidin (Pierce,
Thermo Fisher Scientiﬁc) (Norton et al., 1996) in a 96-well plate for
30 min  in the dark at room temperature on a plate shaker. ProtAG-
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Fig. 1. Capture of peptides using immobilized monoclonal antibody WH303.
A  serial dilution of biotinylated TAVSPTTLR peptides (cf. Table 1) was  incubated with beads carrying immobilized monoclonal antibody WH303 and subsequently captured
peptides were detected with SAPE. Acquired ﬂuorescence is expressed as MFI  and plotted using a logarithmic scale.
Fig. 2. Capture of monoclonal antibodies using immobilized TAVSPTTLR peptides.
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2ix  avidin conjugated bead sets were incubated with six different peptides (cf. Table
eptide  loaded bead sets were used directly (A), or after blocking with biotin (B) 
PBST). Bound WH303 monoclonal antibodies were detected using a PE-labelled go
E was made by conjugating 10 g ProtAG (Pierce, Thermo Fisher
cientiﬁc) with PE using the Lightning Link R-Phycoerythrin con-
ugation kit (Innova BioSciences, Cambridge, United Kingdom).
With beads carrying resp. CSFV1 and 2, most CSFV sera (13 out
f 14) resulted in S/N ratios ranging from resp. 2.0 − 27.1 and 2.3 −
9.7 (without biotin block) or 2.0 − 32.4 and 2.2–30.7 (with biotin
lock) (Fig. 3 A and B). The S/N ratio of serum 87, CSFV-positive
y VNT (Fig. 3C) remained below the calculated cut-offs under
ll conditions tested (peptide loaded beads, with/without biotin
lock). The BVDV and BDV sera gave S/N ratios below the calcu-
ated cut-offs for all conditions tested, as did the sera from pigs with
o pestivirus. These results demonstrate that in suspension arrays
AVSPTTLR derived peptides are speciﬁc for CSFV sera and do not
ross-react with serum antibodies against the other pestiviruses.
Serum 87, negative in the suspension array, was  found seropos-
tive by VNT and in commercial CSFV E2 ELISAs (not shown). This
ay  suggest this particular pig produced an antibody repertoire
hat does not include TAVSPTTLR speciﬁc antibodies.
The results are presented as S/N ratios as to correct for non-
peciﬁc signals using the background signal on the empty control
eads. This is useful to normalize background that is different for
ach serum, e.g. for beads with CSFV1 blocked with biotin three
egative sera (2734-6, 2732-10 and 2741-5) have MFIs between
00 and 350, whereas three negative sera (7257, 7268 and 7269)three concentrations (40–4000 nM), or with no peptides at all (0 nM). The resulting
h monoclonal antibody WH303; a buffer with no antibodies was used as control
imouse antibody. Acquired ﬂuorescence is expressed as MFI.
have MFIs from 47 to 56. These can all be normalized to comparable
S/N ratios (ranging from 0.6 to 1.1), which simpliﬁes the calcu-
lation of a universal cut-off value. Normalization was  especially
relevant for three non-CSFV sera that caused high signals on both
peptide-carrying beads and empty control beads (12, 69, 2013; see
supplemental ﬁles for corresponding MFIs).
Blocking of the beads with biotin during the peptide load-
ing procedure reduced background on empty beads when testing
with monoclonal antibodies. However, for reasons unknown, with
CSFV positive sera an increased signal on non-blocked empty con-
trol beads was not observed. Nevertheless, blocking with biotin
may  eventually become relevant when larger multiplex assays are
designed that require the use of multiple bead sets carrying pep-
tides: in that case, migration of peptides from one bead set to
(free) avidin molecules of another bead set needs to be prevented
(Drummond et al., 2008).
The results presented here show that it is possible to develop a
bead-based suspension array using immobilized peptides to cap-
ture antibodies against the pestivirus CSFV in porcine sera. For the
assay described, peptides containing the linear TAVSPTTLR epitope
of the CSFV E2 protein were immobilized on avidin coated beads
via an N-terminal biotin. This way  of immobilisation is straight-
forward and prevents unfortunate epitope inactivation that may
occur when a classic carbodiimide coupling is attempted from pri-
18 F.J. van der Wal  et al. / Journal of Virological Methods 235 (2016) 15–20
Fig. 3. Detection of porcine serum antibodies against CSFV with a suspension array.
Beads carrying peptide CSFV1 (A) or CSFV2 (B) were used to probe for serum antibodies against CSFV. For each measurement, peptide loaded beads of one type were mixed
with  empty control beads. The beads were used to test a panel of well-characterized porcine sera, that were classiﬁed based on results of VNTs for CSFV, BVDV, and BDV (C)
(cf.  Table 2). Resulting signals on peptide loaded beads were normalized using signals on the empty control beads and expressed as S/N ratios. VNTs: reciprocal titers higher
than  10 represent positive titers; titers have to be at least three times higher between the pestiviruses in order to differentiate between the species.
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Table  2
Sera. A serum panel was  compiled, containing sera from healthy animals and from animals infected with CSFV, BVDV, or BVD. Serological characterization was done by VNT
(Terpstra et al., 1984) with strains Brescia, Osloss and Frijters to establish the presence of antibodies against respectively CSFV, BVDV and BDV, expressed as the reciprocal
titer.  Abbreviations: na = not available, nd = not done.
virus serum strain dpi CSFV BVDV BDV
CSFV 4 Henken/Brescia 3x 84 ≥15360 960 5120
56  E2/Brescia 66 10240 80 120
57  E2/Brescia 66 ≥15360 7.5 80
58  E2/Brescia 66 ≥15360 7.5 80
59  E2/Brescia 66 ≥15360 20 240
60  E2/Brescia 66 ≥15360 30 160
61  Henken/Brescia/E2 85 10240 20 960
62  Henken/Brescia/E2 85 10240 240 1280
63  Henken/Brescia/E2 85 ≥15360 20 320
64  Henken/Brescia/E2 85 10240 20 1280
65  Henken/Brescia/E2 85 10240 120 1280
66  Henken/Brescia/E2 85 10240 80 960
87  E2/Brescia 56 ≥15360 <5 60
88  E2/Brescia 56 ≥15360 <5 30
BVDV  20 Oregon unknown 240 5120 480
23  unknown unknown 40 1280 60
39  Stam 35 10 1280 7.5
53  Ten Breteler 160 480 3840 320
116  St. Oedenrode 77 5 1920 5
117  St. Oedenrode 77 7.5 1280 <5
BDV  1 Frijters 43 10 <5 1280
2  Frijters/Cstrain/Brescia 72 640 320 ≥15360
12  Veghel na 120 10 7680
13  Veghel na 80 10 5120
69  Bantham na 7.5 <5 640
76  Frijters 57 7.5 <5 320
106  Wisman 34 5 10 640
Negative 1997 na na nd nd nd
2013  na na nd nd nd
2732-6  na na nd nd nd
2732-10 na na nd nd nd
2741-5  na na nd nd nd
7257  na na <5 <5 <5
7268  na na <5 <5 <5
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ary amines, which may  also affect the lysine in the TAVSPTTLR
pitope.
While the results of the suspension array correspond with the
erostatus as observed by VNT (bar one), the results do not cor-
elate in a quantitative manner with the observed VNT titers. It
s conceivable that differences are observed as in a VNT multiple
pitopes (and antibody species) may  participate, and/or due to a
ower afﬁnity of serum antibodies for peptide epitopes as opposed
o afﬁnity for the same sequences in their original context.
Although the results hint that in peptide-based assays a spacer
etween biotin and epitope may  be required for the peptide to func-
ion in capture of antibodies, the exact requirements for spacing
ere not investigated and are somewhat obscured by the differ-
nces in composition of the peptides (at the C-termini).
The advantage of suspension arrays is that they can easily be
xpanded with beads carrying new antigens (peptides). For a com-
rehensive pestivirus panel, expansion with peptides speciﬁc for
ntibodies against proteins of BVDV and BDV is required, but also
ith peptides that represent other CSFV speciﬁc epitopes. For
xample, serum 87 is positive by VNT for CSFV, but remained neg-
tive with the current suspension array (cf. Fig. 3) and may  contain
ntibodies against other epitopes than the one used in the sus-
ension array. Currently, work is ongoing to identify peptides that
imic  or represent epitopes of the immunodominant proteins E2
nd Erns of all three pestiviruses (Jelsma, unpublished) as to enable
 complete peptide panel that is capable to detect, and to differen-
iate between, antibodies against the three different pestiviruses.
The assay setup described here was only viable in conjunction
ith a neutravidin pre-treatment of porcine sera. Nevertheless, forna <5 <5 <5
three sera background on empty beads remained very high. In addi-
tion to the use of ProtAG for detection of porcine serum antibodies
instead of secondary antibodies (Van der Wal  et al., 2013), sev-
eral other strategies to reduce background in suspension arrays
have been reported (Martins et al., 2004; Pickering et al., 2010;
Waterboer et al., 2006). It needs to be evaluated if these approaches,
designed for human sera, can be used to prevent background when
investigating porcine sera with beads carrying peptides.
In conclusion, the developed assay speciﬁcally recognizes sera
from animals positive by VNT for CSFV from a panel that also con-
tains sera from healthy animals and from animals infected with
BVDV or BDV, thereby demonstrating the proof of concept of a
peptide-based suspension array for detection of antibodies against
pestiviruses in porcine sera. Once a complete panel of differenti-
ating peptides for all pestiviruses is available, the proof of concept
described here’ can be exploited to develop a complete pestivirus
serological suspension array for use in pigs, suitable for rapid differ-
entiation between serum antibodies against all three pestiviruses
and capable of correctly identifying double infections.
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